Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Viridian Therapeutics, Inc. Common Stock (VRDN)

Viridian Therapeutics (VRDN) stock sees a surge in trading volume and social dominance, hitting a 52-week high in price and Galaxy Score. Recent analyst upgrades and a successful public offering fuel positive sentiment.

### About Viridian Therapeutics, Inc. Common Stock
Viridian Therapeutics, Inc. Common Stock is a biotechnology company focused on therapies for thyroid eye disease.  
Viridian Therapeutics, Inc. Common Stock uses the ticker $VRDN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Viridian Therapeutics, Inc. Common Stock (VRDN) trading volume is up XXXXXX% from the previous X months.
- Viridian Therapeutics, Inc. Common Stock (VRDN) social dominance is up XXX% from the previous week.
- Viridian Therapeutics, Inc. Common Stock (VRDN) posts created is up XXXXX% from the previous month.
- Viridian Therapeutics, Inc. Common Stock Price hit a 52-Week high of $XXXXX for the hour
- Viridian Therapeutics, Inc. Common Stock Galaxy Score™ hit a 52-Week high of XX for the hour
- Viridian Therapeutics, Inc. Common Stock Galaxy Score™ hit an all time of XX for the hour

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/close.tsv)  
The stock has seen positive price action, with recent analyst upgrades and a successful public offering contributing to a potential upside. Social posts indicate a strong upward trend and positive sentiment from traders.  

24-Hour: -XXX%
7-Day: XXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2025-12-04  
1-Year Low: $XX on 2025-04-08  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/alt_rank.tsv)  
Viridian Therapeutics, Inc. Common Stock (VRDN) is currently AltRank #1,342 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX +83  
1-Year High: XXXXX on 2025-12-05  
1-Year Low: XXX on 2025-11-30  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
1-Year High: XX on 2025-12-03  
1-Year Low: XX on 2025-12-02  
  
  
### Engagements: XX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/interactions.tsv)  
Current Value: XX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX +22%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX +6.40%  
1-Year High: XXXXXXX on 2025-01-09  
1-Year Low: XX on 2025-04-21  

Engagements by network (24h):
Reddit: X
X: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XXXX%  
X Month: XXX +72%  
X Months: XXXXX +74%  
X Year: XXXXX +149%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-11  

Mentions by network (24h):
Reddit: X
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Viridian Therapeutics, Inc. Common Stock (VRDN) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +46%  
X Months: XXX +312%  
X Year: XXXXX +242%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-11  

The most influential creators that mention Viridian Therapeutics, Inc. Common Stock in the last XX hours

| Creator                                      | Rank | Followers | Posts | Engagements |
| -------                                      | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron) | X    | XXXXX     | X     | X           |

[View More](/list/creators/$vrdn/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +1%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-26  
1-Year Low: XX% on 2025-12-07  

Most Supportive Themes:
- Analyst Upgrades and Price Targets: (40%) Multiple financial analysts have raised their price targets for Viridian Therapeutics, indicating positive sentiment from the financial community.
- Public Offering and Financial Health: (30%) The company recently completed a significant public offering, bolstering its financial position and providing runway for future development.
- Regulatory Milestones: (20%) Submission of a Biologics License Application (BLA) to the FDA for veligrotug, a key step towards potential market approval.
  
Most Critical Themes:
- Declining Social Media Engagement: (15%) Despite positive company news, social media interest is waning, with notable decreases in engagement and mentions.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXXXX%  
X Week: XXXXXXX% +0.00222%  
X Month: XXXXXXX% +0.0005200000000000001%  
X Months: XXXXXXX% +0.0006199999999999999%  
X Year: XXXXXXX% -XXXXXXX%  
1-Year High: XXXXX% on 2024-12-17  
1-Year Low: XXXXXX% on 2025-10-11  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-11-24  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$2.60%  
1-Year High: $XXXXXXXXXXXXX on 2025-12-04  
1-Year Low: $XXXXXXXXXXXXX on 2025-11-18  

### Top Viridian Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Buy Signal Viridian Therapeutics Inc - X Dec 2025 @ 15:02 - USD31.71"  
[Reddit Link](https://redd.it/1pihonq) [@jvc72](/creator/reddit/jvc72) 2025-12-09T20:47Z X followers, X engagements


"$VRDN Guys Don't miss the next move in a few hours. 💥🚀"  
[X Link](https://x.com/cartoonclu86/status/1997627163978367348) [@cartoonclu86](/creator/x/cartoonclu86) 2025-12-07T11:20Z XX followers, XX engagements


"$VRDN Guys Don't miss the Target price for Next Week. 🔜"  
[X Link](https://x.com/Trade_market6/status/1997341874475204763) [@Trade_market6](/creator/x/Trade_market6) 2025-12-06T16:26Z XXX followers, XX engagements


"Top XX Relative Strength names that are showed up in my Scanner $ONDS $GRAL $LITE $THC $AVGO $MODG $PACS $CIEN $ARMN $TXG $ADPT $COHR $COMM $ARWR $USFD $TSN $TERN $GOOG $GOOGL $VRDN"  
[X Link](https://x.com/Venu_7_/status/1993047844010463431) [@Venu_7_](/creator/x/Venu_7_) 2025-11-24T20:03Z 19.5K followers, 4238 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Viridian Therapeutics, Inc. Common Stock (VRDN)

Viridian Therapeutics (VRDN) stock sees a surge in trading volume and social dominance, hitting a 52-week high in price and Galaxy Score. Recent analyst upgrades and a successful public offering fuel positive sentiment.

About Viridian Therapeutics, Inc. Common Stock

Viridian Therapeutics, Inc. Common Stock is a biotechnology company focused on therapies for thyroid eye disease.
Viridian Therapeutics, Inc. Common Stock uses the ticker $VRDN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Viridian Therapeutics, Inc. Common Stock (VRDN) trading volume is up XXXXXX% from the previous X months.
  • Viridian Therapeutics, Inc. Common Stock (VRDN) social dominance is up XXX% from the previous week.
  • Viridian Therapeutics, Inc. Common Stock (VRDN) posts created is up XXXXX% from the previous month.
  • Viridian Therapeutics, Inc. Common Stock Price hit a 52-Week high of $XXXXX for the hour
  • Viridian Therapeutics, Inc. Common Stock Galaxy Score™ hit a 52-Week high of XX for the hour
  • Viridian Therapeutics, Inc. Common Stock Galaxy Score™ hit an all time of XX for the hour

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock has seen positive price action, with recent analyst upgrades and a successful public offering contributing to a potential upside. Social posts indicate a strong upward trend and positive sentiment from traders.

24-Hour: -XXX% 7-Day: XXXX% 30-Day: XXXXX%

1-Year High: $XXXXX on 2025-12-04
1-Year Low: $XX on 2025-04-08

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Viridian Therapeutics, Inc. Common Stock (VRDN) is currently AltRank #1,342 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX +83
1-Year High: XXXXX on 2025-12-05
1-Year Low: XXX on 2025-11-30

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
1-Year High: XX on 2025-12-03
1-Year Low: XX on 2025-12-02

Engagements: XX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX +22%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +6.40%
1-Year High: XXXXXXX on 2025-01-09
1-Year Low: XX on 2025-04-21

Engagements by network (24h): Reddit: X X: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XXXX%
X Month: XXX +72%
X Months: XXXXX +74%
X Year: XXXXX +149%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-11

Mentions by network (24h): Reddit: X X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Viridian Therapeutics, Inc. Common Stock (VRDN) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX +46%
X Months: XXX +312%
X Year: XXXXX +242%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-11

The most influential creators that mention Viridian Therapeutics, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@seedy19tron X XXXXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +1%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-26
1-Year Low: XX% on 2025-12-07

Most Supportive Themes:

  • Analyst Upgrades and Price Targets: (40%) Multiple financial analysts have raised their price targets for Viridian Therapeutics, indicating positive sentiment from the financial community.
  • Public Offering and Financial Health: (30%) The company recently completed a significant public offering, bolstering its financial position and providing runway for future development.
  • Regulatory Milestones: (20%) Submission of a Biologics License Application (BLA) to the FDA for veligrotug, a key step towards potential market approval.

Most Critical Themes:

  • Declining Social Media Engagement: (15%) Despite positive company news, social media interest is waning, with notable decreases in engagement and mentions.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXXX% +0.00222%
X Month: XXXXXXX% +0.0005200000000000001%
X Months: XXXXXXX% +0.0006199999999999999%
X Year: XXXXXXX% -XXXXXXX%
1-Year High: XXXXX% on 2024-12-17
1-Year Low: XXXXXX% on 2025-10-11

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-24
1-Year Low: XXXXXXX% on 2025-12-09

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$2.60%
1-Year High: $XXXXXXXXXXXXX on 2025-12-04
1-Year Low: $XXXXXXXXXXXXX on 2025-11-18

Top Viridian Therapeutics, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Buy Signal Viridian Therapeutics Inc - X Dec 2025 @ 15:02 - USD31.71"
Reddit Link @jvc72 2025-12-09T20:47Z X followers, X engagements

"$VRDN Guys Don't miss the next move in a few hours. 💥🚀"
X Link @cartoonclu86 2025-12-07T11:20Z XX followers, XX engagements

"$VRDN Guys Don't miss the Target price for Next Week. 🔜"
X Link @Trade_market6 2025-12-06T16:26Z XXX followers, XX engagements

"Top XX Relative Strength names that are showed up in my Scanner $ONDS $GRAL $LITE $THC $AVGO $MODG $PACS $CIEN $ARMN $TXG $ADPT $COHR $COMM $ARWR $USFD $TSN $TERN $GOOG $GOOGL $VRDN"
X Link @Venu_7_ 2025-11-24T20:03Z 19.5K followers, 4238 engagements

Viridian Therapeutics, Inc. Common Stock (VRDN)
/topic/$vrdn